OncoSec - Articles and news items

First patient enrolled in Phase II trial of ImmunoPulse IL-12

Industry news / 17 June 2015 / Victoria White

OncoSec has enrolled the first patient into a Phase II clinical trial of ImmunoPulse IL-12 in patients with squamous cell carcinoma of the head and neck…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+